S824 Humoral Response to Ad26.COV2.S and SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease

Authors :: Valeriya Pozdnyakova
Gregory J. Botwin
Keren L. Appel
Rashmi Kumar
Nirupama Bonthala
Caroline Hwang
David Ziring
Melissa Hampton
Emebet Mengesha
Cindy D. Zamudio
Shane White
null CCRC
Philip Debbas
Diana Benliyan
Anzhelya Makaryan
Yin Li
Justina Ibrahim
Mary Hanna
Angela Mujukian
Susie K. Lee
Andrea Banty
Min Wu
Sandy Joung
Sarah Sternbach
Joseph Ebinger
Kimia Sobhani
Susan Cheng
Dermot McGovern
Jonathan Braun
Gil Melmed
Source :: American Journal of Gastroenterology. 116:S381-S382
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: 2019-20 coronavirus outbreak
Messenger RNA
Hepatology
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Gastroenterology
Medicine
In patient
business
medicine.disease
Virology
Inflammatory bowel disease

Full Text Access

Tools